HPV Vaccine Appears Safe in Early Pregnancy
|
By HospiMedica International staff writers Posted on 14 Apr 2017 |
A new study suggests that vaccination against human papillomavirus (HPV) during pregnancy does not increase the risk of maternal or fetal complications.
Researchers at the Danish Statens Serum Institut conducted a retrospective study of all women in Denmark who had a pregnancy that ended between October 1, 2006, and November 30, 2013. Using nationwide registers, the researchers linked data on quadrivalent HPV vaccination, adverse pregnancy outcomes, and potential confounders. Vaccinated women were matched on a 1:4 ratio with women who were not. Study outcomes included a range of gestational and newborn factors.
The results revealed 65 birth defects in vaccine-exposed pregnancies, compared to 220 in unexposed pregnancies; 20 spontaneous abortions with vaccine exposure versus 131 without; 116 preterm births versus 407; 76 cases of low birth weight versus 277; 171 cases of small size for gestational age versus 783; and two stillbirths versus four. Upon analysis, exposure to HPV vaccine was not associated with significantly higher risks for major birth defect, spontaneous abortion, preterm birth, low birth weight, small size for gestational age, or stillbirth. The study was published on March 30, 2017, in the New England Journal of Medicine (NEJM).
“Our results are consistent with other evidence that does not indicate that the vaccination of pregnant women with inactivated virus, bacterial, or toxoid vaccines generally confers a higher risk of adverse pregnancy outcomes than no such vaccination,” concluded lead author Nikolai Scheller, MD, and colleagues. “Our results also confirm and considerably expand on results from previous studies of the quadrivalent HPV vaccine.”
Introduced in 2006, the quadrivalent HPV vaccine covers the four viral strains most closely associated with gynecologic cancer (HPV-6, 11, 16, and 18). HPV types 6 and 11 also cause genital warts. As of 2014, 58 countries include HPV in their routine vaccinations for all girls around the ages of 9-13, and some countries vaccinate boys as well; the vaccines provide protection for at least eight years. Denmark also vaccinates women up to 26 years of age, and as a result some women are inadvertently exposed to HPV vaccination during early pregnancy.
Researchers at the Danish Statens Serum Institut conducted a retrospective study of all women in Denmark who had a pregnancy that ended between October 1, 2006, and November 30, 2013. Using nationwide registers, the researchers linked data on quadrivalent HPV vaccination, adverse pregnancy outcomes, and potential confounders. Vaccinated women were matched on a 1:4 ratio with women who were not. Study outcomes included a range of gestational and newborn factors.
The results revealed 65 birth defects in vaccine-exposed pregnancies, compared to 220 in unexposed pregnancies; 20 spontaneous abortions with vaccine exposure versus 131 without; 116 preterm births versus 407; 76 cases of low birth weight versus 277; 171 cases of small size for gestational age versus 783; and two stillbirths versus four. Upon analysis, exposure to HPV vaccine was not associated with significantly higher risks for major birth defect, spontaneous abortion, preterm birth, low birth weight, small size for gestational age, or stillbirth. The study was published on March 30, 2017, in the New England Journal of Medicine (NEJM).
“Our results are consistent with other evidence that does not indicate that the vaccination of pregnant women with inactivated virus, bacterial, or toxoid vaccines generally confers a higher risk of adverse pregnancy outcomes than no such vaccination,” concluded lead author Nikolai Scheller, MD, and colleagues. “Our results also confirm and considerably expand on results from previous studies of the quadrivalent HPV vaccine.”
Introduced in 2006, the quadrivalent HPV vaccine covers the four viral strains most closely associated with gynecologic cancer (HPV-6, 11, 16, and 18). HPV types 6 and 11 also cause genital warts. As of 2014, 58 countries include HPV in their routine vaccinations for all girls around the ages of 9-13, and some countries vaccinate boys as well; the vaccines provide protection for at least eight years. Denmark also vaccinates women up to 26 years of age, and as a result some women are inadvertently exposed to HPV vaccination during early pregnancy.
Latest Patient Care News
- Weighted Blankets Reduce Anxiety in Hospitalized Adults
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
Channels
Artificial Intelligence
view channel
AI Framework Aims to Turn Medical Care from Reactive to Preventive
Health systems face rising burdens from aging populations, chronic disease, and workforce shortages. Medical artificial intelligence (AI) remains concentrated in diagnosis and decision support, leaving... Read more
AI Model Predicts Indwelling Catheter Use After Spinal Cord Injury
Patients with early-stage spinal cord injury and neurogenic bladder often face uncertain trajectories in urinary catheter management. Clinicians need tools to anticipate conversion to indwelling catheters... Read moreCritical Care
view channel
Patch-Based Therapy Promotes Myelin Repair in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease that damages the myelin sheath in the central nervous system, leading to progressive disability. After inflammatory attacks, remyelination is often... Read more
Remote Cardiac Device Monitoring System Shows Safety and Cost Benefits
Regular in-clinic follow-up for patients with cardiac implantable electronic devices, including pacemakers and implantable cardioverter defibrillators, is resource intensive. As device use rises with aging... Read moreSurgical Techniques
view channel
Nanobone Material Activates Natural Repair Signals to Regrow Bone
Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more
First Robotic Dual Liver-Kidney Transplant Expands Minimally Invasive Transplant Surgery
Patients with end-stage liver disease often develop renal failure, creating the need for simultaneous liver-kidney transplantation. Traditional open dual-organ transplantation requires large incisions... Read moreMedical Imaging
view channel
Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis
Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
AI-Guided Ultrasound Enables Nonexpert Screening for Aortic Stenosis
Aortic stenosis is a narrowing of the aortic valve that can progress silently until advanced disease. Comprehensive echocardiography is the diagnostic standard, but it requires specialized equipment and... Read moreHealth IT
view channel
Nurse-Coordinated Care Model Improves Heart Failure Outcomes
Heart failure imposes heavy mortality, morbidity, and cost burdens worldwide, yet proven therapies remain underused in routine practice. This inadequate uptake contributes to preventable hospitalizations... Read more
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read morePoint of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read moreBusiness
view channel
Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more







